AbbVie Inc.

NYSE:ABBV

193.62 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q1
Revenue 14,46212,31014,30113,92713,86512,22515,12114,81214,58313,53814,88614,34213,95913,01013,85812,90210,4258,6198,7048,4798,2557,8288,3058,2368,2787,9347,7396,9956,9446,5386,7966,4326,4525,9586,4005,9445,4755,0405,4525,0194,9264,5635,1114,6584,6924,3295,205.7954,5084,4934,172.9484,864.0634,408.6814,274.4453,896.762
Cost of Revenue 2,1764,0822,3866,4854,2403,9864,1705,0224,1704,0524,3204,3904,5234,2134,6845,0503,7111,9422,0061,9201,8191,6942,0221,8351,9341,9272,2801,6161,5281,6161,5551,5041,4051,3691,4751,1679169421,1191,0941,1131,1001,2821,0921,0541,1531,265.3271,0141,0731,156.1671,176.0631,148.6811,107.3381,207.311
Gross Profit 12,2868,22811,9157,4429,6258,23910,9519,79010,4139,48610,5669,9529,4368,7979,1747,8526,7146,6776,6986,5596,4366,1346,2836,4016,3446,0075,4595,3795,4164,9225,2414,9285,0474,5894,9254,7774,5594,0984,3333,9253,8133,4633,8293,5663,6383,1763,940.4683,4943,4203,016.7813,6883,2603,167.1072,689.451
Gross Profit Ratio 0.850.6680.8330.5340.6940.6740.7240.6610.7140.7010.710.6940.6760.6760.6620.6090.6440.7750.770.7740.780.7840.7570.7770.7660.7570.7050.7690.780.7530.7710.7660.7820.770.770.8040.8330.8130.7950.7820.7740.7590.7490.7660.7750.7340.7570.7750.7610.7230.7580.7390.7410.69
Reseach & Development Expenses 1,9171,9391,9211,7231,7332,2921,7901,6141,6091,4971,8271,6731,8021,7821,8901,7061,5821,3791,5422,2851,2911,2896,4951,2681,3221,2441,4021,2221,2231,1351,1901,1061,1249461,0751,418981811879812834772798714709634681.221813642641.968775.129665.521589.759587.097
General & Administrative Expenses 001,4060001,4170001,1600001,431001,6951,9511,6571,6541,6801,9291,9191,7601,7911,9511,4521,5041,3681,6531,3811,4661,3551,7371,4741,7031,4733,3411,5951,4481,3401,4481,2611,4061,2371,410.3571,0851,2461,246.9240001,177.918
Selling & Marketing Expenses 002,2000002,0000002,1000001,8000001,1000001,1000008460007640007040006650006260005060000000
SG&A 3,3423,3003,6063,3723,2683,0393,4173,3045,4123,1273,2603,0833,1642,8423,2312,8463,5271,6951,9511,6571,6541,6801,9291,9191,7601,7911,9511,4521,5041,3681,6531,3811,4661,3551,7371,4741,7031,4733,3411,5951,4481,3401,4481,2611,4061,2371,410.3571,0851,2461,246.9241,134.0322,540.8661,041.0041,177.918
Other Expenses -1,947-586-1,88995-1,412-10-1229-1,533776-216-21-2,658395-4,625-115-802-72-416-177-2,278-135393-94-470153-29-349-62-73-80-101-51012-284-13-221-83-13-5415013-1100000
Operating Expenses 7,2065,2397,4165,0954,8325,3215,2065,1476,8494,6245,0875,2564,8984,6245,1214,5525,1093,0742,6033,9422,9452,9698,4243,1873,5823,0353,3532,6742,7272,5032,8432,4872,5902,3012,8122,8922,6842,2844,7202,4072,2822,1122,2461,9752,1151,8712,091.5781,8981,8881,888.8921,909.1613,206.3871,630.7631,765.015
Operating Income 5,0802,9894,4992,2814,5132,7685,5024,6033,2954,7175,0744,3064,4414,1033,7533,2557523,6033,9562,6173,4003,010-2,4413,1592,7622,9031,7942,7052,6742,4192,3582,3612,3872,2782,1131,8851,8521,687-4151,2101,5151,3511,5351,3711,4531,3051,820.891,5961,422977.8891,378.83953.6131,363.844824.436
Operating Income Ratio 0.3510.2430.3150.1640.3250.2260.3640.3110.2260.3480.3410.30.3180.3150.2710.2520.0720.4180.4550.3090.4120.385-0.2940.3840.3340.3660.2320.3870.3850.370.3470.3670.370.3820.330.3170.3380.335-0.0760.2410.3080.2960.30.2940.310.3010.350.3540.3160.2340.2830.0120.3190.212
Total Other Income Expenses Net -2,934-1,234-3,2874-1,729-1,989-2,304254-1,849606-637-423-2,769316-4,942-180-1,684-77-566-196-2,375-29687-151-47876-661-358-83-86-110-177-136-31210-41-33-292-521-703-29-65-76-236-80-66-51.9737-132-122.097-420.93917.96-155.612-66.114
Income Before Tax 2,1461,7551,2121,9532,6104752,9654,4001,1834,9294,2713,6881,1633,867-1,5072,500-6933,0983,0742,0018072,544-2,3732,7612,0122,7971,1932,0952,3532,0861,9982,0142,0961,7761,9241,6471,6781,396-1,0376871,4331,2861,4391,2861,3681,2391,712.9171,6041,4021,005.7921,357.971.5731,380.732858.322
Income Before Tax Ratio 0.1480.1430.0850.140.1880.0390.1960.2970.0810.3640.2870.2570.0830.297-0.1090.194-0.0660.3590.3530.2360.0980.325-0.2860.3350.2430.3530.1540.2990.3390.3190.2940.3130.3250.2980.3010.2770.3060.277-0.190.1370.2910.2820.2820.2760.2920.2860.3290.3560.3120.2410.2790.0160.3230.22
Income Tax Expense 773383388172583234493448255436226508394312-1,54518746882731176688-5471429141,141464438375607416486422407408312374-227181335306311322300271173.27519135122.514200.33759.238-159.299135.123
Net Income 1,3701,3698221,7782,0242392,4733,9499244,4904,0443,1797663,555362,308-7383,0102,8011,8847412,456-1,8262,7471,9832,783521,6311,9151,7111,3911,5981,6101,3541,5171,2391,3661,022-8105061,0989801,1289641,0689681,539.6421,5851,267883.2781,157.56312.3351,540.031723.199
Net Income Ratio 0.0950.1110.0570.1280.1460.020.1640.2670.0630.3320.2720.2220.0550.2730.0030.179-0.0710.3490.3220.2220.090.314-0.220.3340.240.3510.0070.2330.2760.2620.2050.2480.250.2270.2370.2080.2490.203-0.1490.1010.2230.2150.2210.2070.2280.2240.2960.3520.2820.2120.2380.0030.360.186
EPS 0.780.770.4611.140.131.42.230.522.542.291.780.4220.021.3-0.452.021.891.270.491.65-1.221.811.261.740.0331.021.21.070.870.970.990.830.940.750.840.64-0.510.320.690.610.710.60.670.610.9710.780.550.730.0080.970.45
EPS Diluted 0.780.770.4611.140.131.392.220.512.532.261.780.421.990.011.29-0.452.021.881.260.491.65-1.221.811.261.740.031.011.191.060.850.970.980.830.920.740.830.63-0.510.310.680.610.70.60.660.60.9610.780.540.730.0080.970.45
EBITDA 5,0835,0634,1832,4426,7734,8957,6596,8082,0316,7707,0536,4336,6416,3185,8185,5472,3074,1624,4653,1203,9023,513-1,9993,5943,2053,3482,1633,0843,0532,7932,6862,6652,6762,5462,3742,1122,0421,845-2221,4021,7171,5501,7351,6051,6891,5322,129.751,822.8051,717.0941,297.131,703.715368.8461,681.4541,138.911
EBITDA Ratio 0.3510.4110.2920.1750.4880.40.5070.460.1390.50.4740.4490.4760.4860.420.430.2210.4830.5130.3680.4730.449-0.2410.4360.3870.4220.2790.4410.440.4270.3950.4140.4150.4270.3710.3550.3730.366-0.0410.2790.3490.340.3390.3450.360.3540.4090.4040.3820.3110.350.0840.3930.292